Satellite Symposia

Sunday, June 24

12.30 – 14.30	Roma
Satellite Symposium Organised by Roche
SS2:	Meeting Global Challenges in a NAT Environment
Chair:	J. Saldanha (Roche Molecular Systems, USA)
This symposium will cover a variety of topics of interest to those currently screening blood with nucleic acid amplification techniques or those considering implementing NAT. Subjects covered will include workflow, HBV performance in highly endemic areas, and matching NAT coverage to that currently expected from serology as well as a discussion of future platforms.
12.30 – 12.45	INTRODUCTION
12.45 – 13.10	TOWARDS TOTAL AUTOMATION: PREANALYTIC AUTOMATION COUPLED WITH NAT IN A BLOOD CENTRE IN SPAIN
	M.I. González Fraile (Centro de Hemoterapia de Castilla y León, Valladolid, Spain)
13.10 – 13.35	EPIDEMIOLOGY OF HBV IN ITALY: ARE CURRENT SCREENING STRATEGIES EFFECTIVE?
	C. Velati (Azienda Ospedaliera della Valtellina e Valchiavenna, Sondrio, Italy))
13.35 – 14.00	KOUT OF AFRICA: HIV DIVERSITY AND IMPLICATIONS FOR MOLECULAR DIAGNOSIS
	R. Delgado (Laboratorio de Microbiología Molecular, Madrid, Spain)
14.00 – 14.25	THE PLATFORM OF THE FUTURE
	Speaker to be announced

12.30 – 14.30	Paris
Satellite Symposium Organised by Fenwal
SS1:	Are you ready to go mobile with donor side automation?
Chair:	Dr J.L. Bueno (Madrid, Spain)
12.30 – 12.40	WELCOME AND INTRODUCTION
	J.L. Bueno (Spanish Red Cross, Madrid, Spain)
12.40 – 13.05	IMPACT OF DONOR SIDE AUTOMATION ON MADRID RED CROSS BLOOD CENTRE EFFICIENCY
	J.L. Bueno (Spanish Red Cross, Madrid, Spain)
13.05 – 13.30	NOVEL MOBILE DONATION EXPERIENCE WITH ALYX ON A BUS
	P.O. Forsberg (Bergen, Norway)
13.30 – 13.55	IMPLEMENTATION OF MOBILE COLLECTIONS WITH ALYX IN ENGLAND
	C. Falkner (NHS Blood & Transplant, Leicester, United Kingdom)
13.55 – 14.20	ROUTINE EXPERIENCE WITH 2RBC AND RBC / PLASMA COLLECTIONS AT LIFESHARE
	F. Colvin (LifeShare Blood Centers, Shreveport, LA, USA)
14.20 – 14.30	ADDITIONAL QUESTIONS AND CONCLUDING REMARKS
14.30	ADJOURN
	F. Colvin (LifeShare Blood Centers, Shreveport, LA, USA)

Monday, June 25

13.00 – 15.00	Auditorium A
Satellite Symposium Organised by Chiron
SS3:	Individual Donation (ID)-NAT in the Mediterranean Region – What have we learned?
13.10 – 13.15	WELCOME AND OPENING
	N. Lelie (CHIRON, Suresnes, France)
13,15 – 13.40	GREECE: OCCULT HEPATITIS B, NATIONAL SURVEILLANCE, LOW VIRAL LOAD YIELD CASES
	A. Hatzakis (National Retrovirus Reference Center, Athens, Greece)
13.40 – 14.05	ITALY: NAT & SEROLOGY, EPIDEMIOLOGICAL PATTERNS, HIV TRANSMISSIBILITY, NATIONAL SURVEILLANCE PROGRAMME
	A. Zanetti ( Istituto di Virologia – Università degli Studi di Siena, Milan, Italy)
14.05 – 14.30	SPAIN: ANTI-HBC & HBV-DNA, MOLECULAR EPIDEMIOLOGY, OCCULT CARRIER AND WINDOW PHASE RESIDUAL RISK
	S. Sauleda (Banc de Sang I Texits (BST), Barcelona, Spain)
14.30 – 14.55	DISCUSSION: ISBT HBV SAFETY WORKING GROUP, ID-NAT ALGORITHMS, HBV CONFIRMATION, OCCULT HEPATITIS B AND C
	Moderators : J.P. Allain (University of Cambridge, Cambridge, United Kingdom) J.I. Esteban (Hospital General Universitari Vall d’Hebron, Barcelona, Spain)

13.00 – 15.00	Roma
Satellite Symposium Organised by Gambro
SS4:	Whole Blood Processes made simple

12.30 – 14.30	Madrid
Satellite Symposium Organised by Macopharma
SS5:	Innovations in Blood Safety
Chairs:	Dr Emma CASTRO (Centro de Transfusión de Cruz Roja Española, Madrid, Spain), Prof. Morris BLAJCHMAN (Mc Master University, Hamilton, Canada), Dr Wolfram H. WALKER (MacoPharma, Langen, Germany)
	PLASMA SAFETY:
	Use and results of Methlylene Blue virus inactivated Plasma
	Dr Luis LARREA, Centro de Transfusión de la Comunidad Valenciana, Valencia, Spain
	PLATELETS SAFETY:
	The THERAFLEX UV Platelets procedure for Pathogen Inactivation of Platelet Concentrates
	Dr Harald MOHR, DRK NSTOB, Springe, Germany
	Preliminary data on UVC-treated platelets
	Prof Morris BLAJCHMAN, Mc Master University, Hamilton, Canada
	RED CELLS SAFETY:
	Pathogen Reduction in Red Cell Concentrate: Prion removal filter
	Mr Mike WILTSCHIRE, CDL, NBS Brentwood, England

Tuesday, June 26

12.30 – 14.30	Rome
Satellite Symposium Organised by Contoltechnica
SS6:	Advanced Blood Management: The Hemosafe® System
Chair:	to be confirmed
12.30 – 13.00	SMART BLOOD BANKS AND REMOTE BLOOD MANAGEMENT
	P.P. Pagliaro (Blood Center Director, Mantova, Italy)
13.00 – 13.10	THE “HEMOSAFE®” SYSTEM – GENERAL REMARKS
	L.M.Cappelletti (Angelantoni Industry, Massa Martana, Italy)
13.10 – 13.50	THE “HEMOSAFE®” SYSTEM– PRACTICAL APPLICATIONS
	S. Ventura (Angelantoni Industry, Massa Martana, Italy)
13.50 – 14.15	DISCUSSION
14.15 – 14.30	LUNCH BOXES

12.30 – 14.30	Madrid
Satellite Symposium Organised by Octapharma
SS7:	360º around solvent-detergent plasma
The symposium will review the solvent-detergent plasma from all angles. It will also show data on haemovigilance as well as covering the topic of adverse events related to plasma transfusion with a special focus on TRALI.

12.30 – 14.30	Paris
Satellite Symposium Organised by Cerus
SS8:	A Single Pathogen Inactivation System for Two Blood Components: INTERCEPT Blood System for Platelets and Plasma
Chair:	J.P. AuBuchon (United States of America)
	INTRODUCTION
	J.P. AuBuchon (Dartmouth-Hitchcock Medical Center, Lebanon, Nh, United States of America)
	IMPLEMENTATION IN A HIGH VOLUME CENTER: IN VITRO CHARACTERISTICS OF INTERCEPT PLASMA
	R. Henschler (Germany)
	TWO PATHOGEN INACTIVATED BLOOD PRODUCTS FROM ONE DONATION - TREATMENT OF PLATELETS AND CONCURRENT PLASMA
	E. Castro (Centro Transfusión. Cruz Roja Española, Madrid, Spain)
	SYNERGY OF INTERCEPT PLATELETS AND PLASMA IN ROUTINE USE
	J-P. Cazenave (Établissement Français du Sang-Alsace, Strasbourg, France)

↑ top